Rakesh Kumar Tekade

Biography

"PDF: UT Southwestern Medical Centre, Dallas, Texas, USA PDF:University of Hawaii, Hilo, Hawaii, USA Ph.D:Dr Hari Singh Gour Central University, Sagar, India (2011) Commonwealth Split Site Ph. D Fellow:University of Central Lancashire, Preston, UK (2009) M. Pharm (Pharmaceutics)Dr Hari Singh Gour Central University, Sagar, India (2006) B. Pharm:Rajiv Gandhi Technical University, Bhopal, India (2004). Experience July 2016 - Present: Assistant Professor (Pharmaceutics), NIPER-Ahmedabad (India) Aug 2014-May 2016: Lecturer in Pharmaceutical Technology, School of Pharmacy, International Medical University, Kuala Lumpur (KL), Malaysia Aug 2013 - Jun 2014: Postdoctoral Fellow-II, , University of Texas, UT Southwestern Medical Centre, Dallas, USA Jul 2011 – Aug 2013: Postdoctoral Fellow-I, University of Hawaii, College of Pharmacy, Hilo, Hawaii, USA Mar 2008 – Jun 2011: Senior Research Fellow (SRF-CSIR), Awarded by Council of Scientific & Industrial Research (CSIR), New Delhi, India for pursuing Ph. D, availed at Dr. Hari Singh Gour Central University, Sagar, India Aug 2009 – Aug 2010 : Commonwealth Fellow, University of Central Lancashire, Preston, UK Apr 2009 : National Doctoral Fellow, All India Council of Technical Education (AICTE), New Delhi, India Sep 2007 – Mar 2008 : Scientist (F & D), Ranbaxy Pharmaceuticals ltd, Dewas, India Jul 2006 – Sep 2007 : Lecturer of Pharmaceutics,BITS College of Pharmacy, Bhopal, India 2004-2006 : Junior Research Fellow (JRF-AICTE),Awarded by All India Council of Technical Education (AICTE), New Delhi, India for pursuing M. Pharm, availed at Dr. Hari Singh Gour Central University, Sagar, India Honors and Awards Fundamental Research Grant, 133000 Ringgit, Ministry of Health, Malaysia. Industrial Research and Development fund, 70,000 Ringgit, InQ Pharmaceuticals SDN BhD, Malaysia IMUJC Graduate Research Fund, IMU, Kuala Lumpur, Malaysia Research Grant, UT Southwestern Medical Centre, Dallas, Texas, USA Research Grant, University of Hawaii, Hilo, USA Visiting Commonwealth Fellowship, University of Central Lancashire, Preston, UK. IRISH Research Council Government Postdoctoral Award Travel Grant, Controlled Release Society Conference, University of Hawaii, Hilo, USA Best paper award in the field of pharmacy from India, Mottan Devi Dandiya Trust, India (Awarded for a paper in ACS Chemical Reviews, Impact Factor 45.5) Best Presentation Award, Royal Chemical Society, UK-Malaysia Joint Conference, Malaysia Guest Editor, Current Pharmaceutical Design (Bentham Publisher), Impact factor: 3.3 Travel grant, Society of Nuclear Medicine Conference, UT Southwestern Medical University, Dallas, Texas, USA Travel Grant, Int. Conference on Biomedical Application of Dendrimer (France), British Council, London, UK Young Scientist Award, 1st International conference on innovative pharmacy and pharmaceutical sciences, India Young Scientist Award, National Science Day, Dr. H. S. Gour University, India SRF, CSIR, New Delhi, India National Doctoral Fellowship (NDF), AICTE, New Delhi, India JRF, AICTE, New Delhi, India Grant reviewer, Fondecyt Funds, Chile Editorial Board Member, Int. J. Pharm. Sci. Res., Int. J. Pharm. Pharma. Sci., Am.J. Phytomed. Clin.Ther., Pharm. Asp. J., Am. J. Pharm. Sci. Nanotechnol."

Research Interest

Dr Rakesh K Tekade, Assistant Professor of the Department of Pharmaceutics, investigates the design, development and characterization of targeted nanotechnology based formulations for the site specific delivery of therapeutic drugs, siRNA, microRNA, plasmids, proteins and peptide for the treatment of cancer. An overarching goal of his current research interests encompass development of novel polymeric nanomaterial for effective cytosolic delivery of anticancer bioactives. Dr Tekade’s research is focused on designing a new generation of nanoparticles, which could identify the cancer cells and selectively deliver anticancer drugs and genes to inhibit the growth of cancer while sparing healthy tissues. His research work involves the applications of polymer chemistry, nanotechnology, molecular biology, pharmacokinetics/pharmacodynamics and imaging techniques. Tekade has also investigated the anticancer activity and molecular mechanism of several compounds and nanoformulations against cancer cell lines. Dr Tekade has 70 publications (>1650 citations; H–index of 21; cumulative Impact Factor: 274.10), 01 patent, 07 book chapters, and 03 editorial articles. He has delivered several invited research talks and presented research finding in more than 30 scientific conferences.